Third Harmonic Bio Analyst Ratings
Third Harmonic Bio Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
2022 年 10 月 10 日 | — | Cowen & Co. | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
Third Harmonic Bio Questions & Answers
第三諧波生物學問答
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Cowen & Co. on October 10, 2022. The analyst firm set a price target for $0.00 expecting THRD to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Cowen & Co. 於2022年10月10日公佈了第三諧波生物(納斯達克股票代碼:THRD)的最新目標股價。該分析公司將目標股價定爲0.00美元,預計THRD將在12個月內降至12個月內(可能下跌-100.00%)。1家分析公司去年公佈了評級。
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Cowen & Co., and Third Harmonic Bio initiated their outperform rating.
Cowen & Co. 對第三諧波生物(納斯達克股票代碼:THRD)的最新分析師評級由Cowen & Co. 提供,Third Harmonic Bio啓動了跑贏大盤的評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on October 10, 2022 so you should expect the next rating to be made available sometime around October 10, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表、與Third Harmonic Bio的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。Third Harmonic Bio的最後一次評級是在2022年10月10日提交的,因此您應該預計下一個評級將在2023年10月10日左右公佈。
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $0.00. The current price Third Harmonic Bio (THRD) is trading at is $20.01, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的第三諧波生物(THRD)評級最初設定爲0.00美元至0.00美元。Third Harmonic Bio(THRD)目前的交易價格爲20.01美元,超出了分析師的預期區間。